Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development

por Chêne, Arnaud, Gangnard, Stéphane, Dechavanne, Célia, Dechavanne, Sebastien, Srivastava, Anand, Tétard, Marilou, Hundt, Sophia, Leroy, Odile, Havelange, Nicolas, Viebig, Nicola K., Gamain, Benoît
Publicado 2018

Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report

por Chêne, Arnaud, Houard, Sophie, Nielsen, Morten A., Hundt, Sophia, D’Alessio, Flavia, Sirima, Sodiomon B., Luty, Adrian J. F., Duffy, Patrick, Leroy, Odile, Gamain, Benoit, Viebig, Nicola K.
Publicado 2016

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

por Doritchamou, Justin, Nielsen, Morten A., Chêne, Arnaud, Viebig, Nicola K., Lambert, Lynn E., Sander, Adam F., Semblat, Jean-Philippe, Hundt, Sophia, Orr-Gonzalez, Sachy, Janitzek, Christoph Mikkel, Spiegel, Alicia J., Clemmensen, Stine B., Thomas, Marvin L., Nason, Martha C., Snow-Smith, Maryonne, Barnafo, Emma K., Shiloach, Joseph, Chen, Beth B., Nadakal, Steven, Highsmith, Kendrick, Ouahes, Tarik, Conteh, Solomon, Sharma, Ankur, Torano, Holly, Butler, Brandi, Reiter, Karine, Rausch, Kelly M., Scaria, Puthupparampil V., Anderson, Charles, Narum, David L., Salanti, Ali, Fried, Michal, Theander, Thor G., Gamain, Benoit, Duffy, Patrick E.
Publicado 2023